CIK 0001681087
- Non-accelerated filer
- Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 810710585
- Phone
- +1 339-666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Medical Officer sold 1,065 shares at $30.00 ($31,950)
- 4 Planned sale Chief Medical Officer sold 1,000 shares at $31.05 ($31,050)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Medical Officer sold 10,000 shares at $30.00 ($300,000)
- 4 Planned sale Chief Scientific Officer sold 6,262 shares at an average $30.17 ($188,935)
- 4 Grant or award Chief Executive Officer acquired 76,500 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 19,500 shares (grant or award)
- 4 Planned sale Chief Scientific Officer sold 3,299 shares at an average $23.53 ($77,627)
- 4 Grant or award Chief Financial Officer acquired 26,500 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 26,500 shares (grant or award)
- 4/A Open-market buy Chief Executive Officer bought 2,500 shares at $21.10 ($52,750)
- 4 Open-market buy Chief Executive Officer bought 2,500 shares at $21.10 ($52,750)
- 4 Exercise or conversion Chief Business Officer acquired 4,500 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 6,000 shares at $21.61 ($129,660)
- 4 Shares withheld for taxes Chief Business Officer gave up 1,619 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 2,064 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 4,104 shares (to pay taxes)
Page 2 of 12 · 226 filings